Prospective Study for the Use of Palivizumab (Synagis®) in High-risk Children in Germany
NCT01155193
·
clinicaltrials.gov ↗
COMPLETED
Status
30804
Enrollment
INDUSTRY
Sponsor class
Conditions
Respiratory Syncytial Virus Infections
Sponsor
AbbVie (prior sponsor, Abbott)